Conjugated linoleic acids (CLA) have been demonstrated to be a potent inhibitor of milk fat synthesis in ruminants, but effects on carcass composition and organ weight are unknown. Our objectives in this experiment were to determine the dose response of ruminally protected CLA on the performance, organ weight, and fatty acid (FA) composition of early lactation dairy ewes. Twenty-four multiparous dairy ewes were fed a basal diet for 10 wk that was supplemented with a lipid-encapsulated CLA at 1 of 3 levels: no CLA (control, CON), low CLA (L-CLA), or high CLA (H-CLA) to supply 0, 1.5, or 3.8 g/d, respectively, of both trans-10, cis-12 and cis-9, trans-11 CLA. Dry matter intake was not affected (P . cis-9, trans-11 and trans-10, cis-12 CLA were increased in ewes receiving H-CLA. The current findings are consistent with the view that the energy spared by the CLA reduction in milk fat content was mainly partitioned to milk yield and there was no evidence of organ hypertrophy or liver steatosis.
Introduction
Conjugated linoleic acids (CLA) 9 are produced in the rumen as intermediaries in the biohydrogenation of linoleic acid by bacteria (1) . Much attention has focused on the effects of the trans-10, cis-12 CLA isomer on milk fat depression (MFD) in dairy cows, where it is well established that there is a dose response and a maximum inhibitory effect on milk fat synthesis of 50% (2) . More recently, 2 other isomers, trans-9, cis-11 CLA and cis-10, trans-12 CLA, have also been demonstrated to have potent MFD effects in dairy cows (3, 4) . The MFD response to trans-10, cis-12 CLA has been demonstrated in other ruminants, including caprines (5, 6) and ovines (7, 8) . In ovines, it has been shown that MFD following CLA supplementation is comparable to that in dairy cows (7, 8) , although most studies conducted to date have fed single doses and the dose response relationship of CLA and MFD is not well established.
The influence of CLA on mammary milk fat synthesis is readily quantifiable in lactating ruminants, because milk yield and composition are easily measured, but the effects on body fat deposition are more difficult to determine (9) . CLA supplements have been shown to reduce body fat or body fat depots in several species, including mice, rats, pigs, and humans, and this effect is due to the trans-10, cis-12 CLA isomer (10) . In contrast to these observations, CLA supplementation did not affect perirenal or carcass fat content in growing lambs (11) . Similarly, in beef cattle, supplementary CLA did not alter carcass or kidney and pelvic fat content (12) . There have been, however, no studies to our knowledge in lactating ruminants that have simultaneously examined the dose response of CLA on milk fat synthesis and whole body fat deposition.
Early lactation is characterized in mammals by a mobilization of body fat from adipose tissue depots (13) and this often results in an increase in hepatic lipid content (14, 15) . It has been estimated that~45% of dairy cows in early lactation have a moderate steatosis of the liver (16) , which is associated with metabolic disorders such as displaced abomasum, ketosis, metritis, and impairment of reproductive performance (14) . There is evidence from some (17) but not all (18, 19) studies with laboratory animals that trans-10, cis-12 CLA increases internal organ weight, particularly that of the liver, in a dose-dependent manner and may result in liver steatosis. There have, however, been no studies to our knowledge in lactating ruminants that have examined the effect of CLA supplementation on internal organ weight, although hepatic lipid content was unaffected in dairy cows receiving CLA supplements (20, 21) .
Our objectives in this study were to examine the dose effect of a rumen-protected formulation of CLA on the performance, carcass composition, organ weight, and fatty acid (FA) composition in early lactation dairy ewes.
Materials and Methods
Animals and treatments. The experiment was conducted in accordance with the UK Animals (Scientific Procedures) Act 1986. At 16 (61.6) d postpartum, 24 multiparous Friesland (n = 18) and British Milk Sheep (n = 6) ewes were randomly allocated to 1 of 3 treatments based on their breed, milk yield and milk fat yield measured in the previous 7 d, body weight, and body condition score [BCS (22) ]. Ewes were milked twice daily at 0800 and 1600 h through a standard ewe milking parlor and fed a basal ration (ratio of concentrates:forage = 0.55:0.45, dry matter basis; Table 1 ) with fresh feed offered once daily, immediately after milking, at the rate of 1.05 times ad libitum consumption. The diets were supplemented with a lipid-encapsulated CLA product that contained 2 CLA isomers in equal proportions: cis-9, trans-11 and trans-10, cis-12 (Lutrell; BASF SE). The production and general characteristics of the lipid-encapsulated CLA product have been previously described (7) and the FA composition is given in a Table  1 footnote.
The CLA supplement was fed at 1 of 3 levels: no CLA (control, CON); low (L-CLA), 15 g/d; or high (H-CLA), 40 g/d, which supplied 1.5 or 3.8 g/d of trans-10, cis-12 and an equal amount of cis-9, trans-11 CLA for L-CLA and H-CLA, respectively. These levels were chosen because they were 60 and 160% of that used in previous studies that have produced milk fat content reductions of 23% (7, 8) . The supplement was weighed for each ewe on a daily basis, spread on top of the ration, and consumed within 5 min of being offered. The ewes received one of the experimental treatments throughout a 10-wk period in a randomized block design. Body weight and condition score of each were recorded every 2 wk. Feed samples were collected weekly, stored at 2208C, and composited at the end of the study prior to analysis. Milk yield was recorded weekly and samples collected over 2 consecutive milkings for subsequent analysis of fat and protein. During wk 10 of the study, additional samples were collected and stored at 2208C for subsequent FA analysis.
At the end of the experimental period, all ewes were slaughtered over a 72-h period by stunning and exsanguination. Immediately postslaughter, carcasses were eviscerated, skinned, and weights recorded. Carcasses were then split down the spinal column into halves and back fat thickness recorded between the 10th and 11th thoracic vertebrae and 5th and 6th lumbar vertebrae using a digital caliper. Right halves of the carcasses were stored at 2208C for subsequent chemical analysis.
Tissue collection and FA analysis. Immediately following slaughter, body organs were collected and weighed. Three transverse slices (#1 cm wide and 10 cm long) across the midpoint of each of the left, right, and quadratic lobes of the liver were taken and any visible connective or vascular tissue dissected out. Five cubes from the center of each of the 3 slices (#1.0 cm in any dimension, 15 cubes in total) were taken and stored at 2208C. Between the 9th and 14th ribs of the left side of the carcass, Longissimus dorsi (LD) muscle was dissected out and all visible external fat and connective tissue trimmed off. Three transverse sections (#1.0 cm thick, 10 cm long) across the muscle at approximately equal distances were taken and 5 cubes from the center of each of the 3 sections (#1.0 cm in any dimension, 15 cubes in total) were stored at 2208C. Connective and vascular tissues around the heart was removed and the left ventricle dissected out and 15 cubes (#1.0 cm in any dimension) were taken and stored at 2208C. Depending on the amount of fat available,~50-200 g of perirenal fat covering the left kidney was removed and stored at 2208C.
Chemical analysis. Feed samples were analyzed according to AOAC (23) for dry matter (934.01) and crude protein (988.05) and neutral detergent fiber was analyzed according to Van Soest et al. (24) . Lipids in the feed samples were extracted, methylated, analyzed, and quantified (25) 
Carcass gross energy content was determined by bomb calorimeter (Isoperibol Calorimeter).
Calculations and statistical analysis. Milk energy output (MJ/d) was calculated according to AFRC (27) . Milk production and composition, body weight, and BCS score were analyzed as a randomized block using repeated-measures ANOVA. Milk FA composition, carcass parameters, and tissue FA composition were analyzed by ANOVA as a randomized block design. Differences between individual treatments were tested using a Student's t test. All analyses were conducted using Genstat 10.1 (VSN Int. Ltd.) and results are presented as treatment means with SEM, with differences considered significant at P , 0.05.
Results
Animal performance and milk FA composition. Dry matter intake was not affected by dietary treatment ( Table 2) . Ewes fed H-CLA had a 13% higher (P = 0.05) milk yield compared with those receiving either CON or L-CLA compared with CON, milk fat percent was 15 and 34% lower for ewes receiving L-CLA or H-CLA, respectively. Similarly, compared with CON, daily milk fat yield was reduced by 14 and 24% in ewes fed L-CLA or H-CLA, respectively. The effects of CLA supplements on milk FA composition are presented in Supplemental Table 1 . Summarizing, the CLA-induced decrease in milk fat was due principally to a reduction in de novo synthesis of FA of ,16 or 16:0 + 16:1 carbons (Table 2 ). Milk protein content and yield, milk net energy output, body weight, body weight change, and BCS were not affected by CLA supplementation, but daily protein yield tended (P = 0.07) to be higher in ewes fed H-CLA compared with CON-fed ewes. The temporal pattern indicated that daily milk yield was similar in ewes fed the CON or L-CLA treatments throughout the study period but was higher (P , 0.05) in ewes fed H-CLA in wk 4, 5, 6, 8, and 9 ( Fig. 1) . Within 1 wk of treatment, the milk fat content of ewes fed H-CLA was lower (P , 0.05) than those fed CON or L-CLA and from wk 3 of the study ewes fed L-CLA had a lower (P , 0.05) milk fat content than CON, an effect that was sustained throughout the treatment period. Similarly, milk fat yield of ewes fed H-CLA declined rapidly following CLA supplementation, being lower (P , 0.05) than of those fed CON during wk 2-7.
Organ weight, carcass characteristics, and composition. Supplementing ewes with CLA did not affect organ or carcass weight, liver lipid content, or carcass composition ( Table 3) . In contrast, CLA supplementation reduced back fat thickness between the 10th and 11th thoracic vertebrae compared with the CON treatment, with the reduction being of similar magnitude for the 2 levels of CLA supplementation. Compared with ewes receiving the CON treatment, CLA supplementation had little effect on the FA composition of the LD, except for cis-9, trans-11, which was increased in ewes receiving H-CLA, and trans-10, cis-12 CLA and 22:6(n-3,) which were increased in ewes receiving L-CLA or H-CLA ( Table  4 ). In contrast, there was an incremental increase in the content of trans-11 18:1 and a decrease in cis-9 16:1 in the heart muscle, perirenal fat, and liver in ewes that received CLA. In addition, there was a dose-dependent increase in the liver content of 18:0 
Discussion
Animal performance. It is well established in dairy cows and ewes that supplementation with ruminally protected CLA reduces milk fat yield (7, 8, 28) . In contrast, conditions under which CLA supplementation alters intake, milk yield, or energy partitioning toward body lipid reserves are less well understood. For example, a meta-analysis of short-term abomasal infusion of mixed isomers of CLA in dairy cows indicated a reduction in voluntary intake of 7% (9), which accounted for a major proportion of the energy spared in MFD in dairy cows. Intake was, however, unaffected by the rate of inclusion of CLA in the current study, a finding in agreement with other longer term studies that have supplemented dairy cows (20, 21, 29, 30) Milk fat content in the current study decreased in a dosedependent manner with CLA inclusion, with a 15 and 34% reduction at the 1.5-and 3.8-g/d supplementation rate, respectively. Using the dose response relationship of daily CLA intake and MFD reported for dairy cows (2) and extrapolating to sheep on a metabolic liveweight basis predicts a decrease in milk fat yield of 17 and 34% at the low and high levels of CLA inclusion, respectively. These predicted values are remarkably similar to the 14% reduction in daily milk fat yield that was observed for ewes receiving L-CLA compared with CON but greater than the 24% reduction in milk fat yield for H-CLA, primarily due to the increase in milk yield that was observed for ewes receiving this treatment. These findings, together with a previous study (7) , suggest that the energy spared due to the reduction in milk fat yield with supplementation of trans-10, cis-12 CLA may, under certain circumstances, increase milk yield. When differences in milk fat content are considered, milk net energy output did not differ among the 3 dietary treatments (P = 0.25). In dairy cows, several studies have reported no effect on milk yield of infusing or supplementing with rumen-protected CLA (20, (29) (30) (31) , but in others, particularly when cattle have been grazed or fed at a restricted level of energy intake, there is a significant increase in yield (21, (32) (33) (34) . In contrast, we have previously found no effect of supplementing CLA at 2.4 g/d on milk yield in dairy ewes when fed at a restricted level of energy intake (8) . Similar to the findings in the present study, increasing the dose of supplementary rumen-protected CLA did not affect body weight or BCS in studies conducted with dairy cows (20, 30, 31) . In contrast, milk energy spared by the inclusion of a rumen-protected source of CLA linearly increased BCS in dairy ewes, with no effect on milk yield or intake (35) , although reasons for this response are unclear. Further research is required to determine the conditions under which the energy spared by MFD increases milk yield and body fat reserves or reduces voluntary intake in ruminants.
In this study, H-CLA supplementation resulted in a decrease of over 49% in the daily output of short-chain milk FA of , 16 carbons, which are indicative of de novo synthesis and contribute~50% of milk FA, but there was no effect on milk fat secretion of FA . 16 carbons, which are a reflection of absorption from the blood stream (28) . As a consequence, the profile of milk fat was shifted toward an increased proportion of long-chain FA. Other studies in sheep (7, 8) and dairy cows [see reviews (1, 28) ] have reported a decline in the daily yield of FA of all chain lengths, although proportionally, the effect of CLAinduced MFD is greatest in FA of , 16 carbons. Others have shown that the CLA-induced decrease in de novo-synthesized FA is associated with a downregulation of key lipogenic enzymes and lipogenic regulatory proteins in the mammary gland, including sterol response element-binding protein 1 and Spot 14 (36) .
Organ weight and carcass composition. This is the first study, to our knowledge, to investigate the effect of supplemental CLA on organ weight and carcass composition in lactating ruminants. In nonlactating laboratory animals, some studies in rats (37) have indicated an increase in internal body organ weight following CLA supplementation, whereas in mice (38, 39) and hamsters (17) , the increase appears to be mainly in the liver. There is, however, no evidence from the current study that CLA supplementation for 10 wk at doses that caused MFD had any effect on organ weight in lactating ewes. Furthermore, liver mass (P = 0.48), hepatic lipid content (P = 0.25), and total hepatic lipid yield (P = 0.81) did not differ among treatment groups in the present study (Table 3) . This contrasts sharply with trans-10, cis-12 CLA-supplemented mice, where liver hypertrophy is observed and hepatic triglyceride increases can be .300% [e.g. (40,41) ]. However, mice appear to be the exception and CLA-induced increases in liver lipids have generally not been observed for other species [see reviews (42) (43) (44) ]. In the current study, dietary treatment also had no effect on liver FA concentration (Table 4 ) and regression of liver mass (as a percent of body weight) and hepatic FA concentration on daily intake of CLA revealed no relationship (P . 0.16). Similar to the current findings, liver lipid content was unaffected by CLA supplementation in early lactation dairy cows (20, 21) . Therefore, unlike reports for mice, CLA at doses that are effective at reducing milk fat synthesis had no detrimental effect on liver mass or hepatic fat levels in lactating ruminants.
In growing mice, a decrease in body fat accretion has been reported following CLA supplementation (43, 45) , which was associated with an increase in basal metabolic rate and energy expenditure of up to 75% (39) . In growing ruminants, the 1 Values are means, n = 8. Means in a row with superscripts without a common letter differ, P , 0.05. 2 Calculated as the product of liver weight and lipid concentration 3 Thickness of back fat between 10th and 11th thoracic vertebrae. 4 Thickness of back fat between 5th and 6th lumbar vertebrae. situation appears different, with no effect on body fat levels being reported in growing lambs or beef animals (11, 12) . In the current study, there was a decrease in fat depth over the 10th and 11th thoracic vertebrae, but not the 5th and 6th, and overall there was no effect of CLA supplementation on carcass or noncarcass fat levels or the gross energy content of the carcass. Additionally, calculated net energy balance (metabolizable intake -metabolizable output for maintenance and milk) did not differ among the 3 treatments, with mean values of +5.0, +5.9, and +6.3 MJ/d (SEM 0.63; P = 0.26). This finding suggests that in the case of the H-CLA dose, energy was repartitioned from milk fat synthesis to support an increased output of milk and milk protein ( Table 2) .
Tissue FA content. There have been no previous studies to our knowledge in lactating ruminants that have reported the effect of supplemental CLA on FA composition in different body tissues. Similar to the effects on carcass and noncarcass components, tissue total fat content, measured as the sum of the individual FA, was not affected by treatment. Although there was no detectable trans-10,cis-12 CLA in the CON treatment for the tissues examined, CLA supplements resulted in an increase in the FA content of both trans-10,cis-12 and cis-9, trans-11 CLA isomers (Table 4 ). Comparing the 2 CLA isomers, supplementation generally resulted in a greater absolute magnitude of increase for cis-9, trans-11 CLA. These findings are remarkably similar to that reported for liver and perirenal fat tissues in growing lambs when fed a rumen-protected CLA at a similar dose to that used here (11) . Taken in combination, these results indicate a similar enrichment in tissue CLA composition in growing and lactating sheep following supplementation, despite the well-documented effects of CLA on altering mammary metabolism and subsequent milk fat content and composition. The proportion of 18:1 trans-11 in tissue fat was increased by CLA supplementation. This is probably due to the an incomplete rumen protection of the CLA supplement, so that some of the unsaturated FA in the formulation were biohydrogenated (46) . In agreement, there was an increase in the proportions of 18:1 trans-11 in liver, muscle, and perirenal fat in growing lambs fed CLA, whereas 18:1 trans-10 was increased in only the perirenal fat (11) . The increased tissue proportions of 18:1 trans-11 associated with CLA supplementation would also have resulted in an increase in substrate available for stearoyl-CoA desaturase to produce cis-9, trans-11 CLA (11); this would explain the relatively greater increase in tissue cis-9, trans-11 CLA, because stearoyl-CoA desaturase has been shown to increase in adipose tissue from lactating dairy cows supplemented with CLA (9) . Additionally, the rate of oxidation of trans-10, cis-12 CLA within tissues is higher than that of cis-9, trans-11 CLA (19).
In conclusion, the results of the present study demonstrate that rumen-protected CLA supplementation to dairy ewes reduced milk fat content and yield in a dose-dependent manner. Carcass energy content was unaffected by CLA supplementation, but at the higher level of CLA inclusion, the energy spared by the reduction in milk fat was repartitioned to support an increase in milk yield. Supplementation of rumen-protected CLA had no effect on gross carcass characteristics, organ weights, or carcass composition and there was no evidence of organ hypertrophy or liver steatosis.
